Iron metabolism in BeWo chorion carcinoma cells. Transferrin-mediated uptake and release of iron.
Growing human choriocarcinoma BeWo b24 cells contain 1.5 X 10(6) functional cell surface transferrin binding sites and 2.0 X 10(6) intracellular binding sites. These cells rapidly accumulate iron at a rate of 360,000 iron atoms/min/cell. During iron uptake the transferrin and its receptor recycle at least each 19 min. The accumulated iron is released from the BeWo cells at a considerable rate. The time required to release 50% of previously accumulated iron into the extracellular medium is 30 h. This release process is cell line-specific as HeLa cells release very little if any iron. The release of iron by BeWo cells is stimulated by exogenous chelators such as apotransferrin, diethylenetriaminepenta-acetic acid, desferral, and apolactoferrin. The time required to release 50% of the previously accumulated iron into medium supplemented with chelator is 15 h. In the absence of added chelators iron is released as a low molecular weight complex, whereas in the presence of chelator the iron is found complexed to the chelator. Uptake of iron is inhibited by 250 microM primaquine or 2.5 microM monensin. However, the release of iron is not inhibited by these drugs. Intracellular iron is stored bound to ferritin. A model for the release of iron by BeWo cells and its implication for transplacental iron transport is discussed.
D002460:Cell Line; D002822:Choriocarcinoma / Q000378:metabolism*; D004705:Endocytosis; D005260:Female; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007700:Kinetics; D008985:Monensin / Q000494:pharmacology; D011247:Pregnancy; D011319:Primaquine / Q000494:pharmacology; D011990:Receptors, Transferrin / Q000378:metabolism*; D014168:Transferrin / Q000378:metabolism*; D014594:Uterine Neoplasms / Q000378:metabolism*
D011990:Receptors, Transferrin; D014168:Transferrin; D008985:Monensin; D007501:Iron; D011319:Primaquine